LJPC - La Jolla Pharmaceutical Company

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5748.73M
Enterprise Value 3626.37M
Trailing P/E N/A
Forward P/E 1-8.87
PEG Ratio (5 yr expected) 1-0.54
Price/Sales (ttm)5,804.10
Price/Book (mrq)5.60
Enterprise Value/Revenue 34,855.56
Enterprise Value/EBITDA 6-6.57

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)-74,665.90%
Management Effectiveness
Return on Assets (ttm)-47.52%
Return on Equity (ttm)-80.11%
Income Statement
Revenue (ttm)129k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)616k
EBITDA -95.32M
Net Income Avi to Common (ttm)-96.11M
Diluted EPS (ttm)-5.12
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)141.32M
Total Cash Per Share (mrq)6.39
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)17.41
Book Value Per Share (mrq)6.04
Cash Flow Statement
Operating Cash Flow (ttm)-75.53M
Levered Free Cash Flow (ttm)-43.17M

Trading Information

Stock Price History
Beta 1.58
52-Week Change 379.70%
S&P500 52-Week Change 317.63%
52 Week High 339.28
52 Week Low 316.41
50-Day Moving Average 334.53
200-Day Moving Average 331.81
Share Statistics
Avg Vol (3 month) 3275.19k
Avg Vol (10 day) 3152.73k
Shares Outstanding 522.15M
Float 11.8M
% Held by Insiders 16.57%
% Held by Institutions 1109.97%
Shares Short 34.56M
Short Ratio 323.18
Short % of Float 331.48%
Shares Short (prior month) 34.63M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/50
Last Split Date 3Jan 14, 2014